Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes

Gunnar H Gislason, Jeppe Nørgaard Rasmussen, Steen Z Abildstrom, Tina Ken Schramm, Morten Lock Hansen, Nina Pernille Gardshodn Buch, Rikke Sørensen, Fredrik Folke, Niels Gadsbøll, Søren Rasmussen, Lars Køber, Mette Madsen, Christian Torp-Pedersen

154 Citationer (Scopus)

Abstract

Undertreatment with recommended pharmacotherapy is a common problem in heart failure and may influence prognosis. We studied initiation and persistence of evidence-based pharmacotherapy in 107,092 patients discharged after first hospitalization for heart failure in Denmark from 1995 to 2004.
OriginalsprogEngelsk
TidsskriftCirculation
Vol/bind116
Udgave nummer7
Sider (fra-til)737-44
Antal sider8
ISSN1213-7537
DOI
StatusUdgivet - 14 aug. 2007

Fingeraftryk

Dyk ned i forskningsemnerne om 'Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes'. Sammen danner de et unikt fingeraftryk.

Citationsformater